Results 171 to 180 of about 2,472,817 (358)
LYMPHANGIOPLASTY: A NEW METHOD FOR THE RELIEF OF THE BRAWNY ARM OF BREAST-CANCER AND FOR SIMILAR CONDITIONS OF LYMPHATIC ŒDEMA. [PDF]
, 1908 W. Sampson Handley
openalex +1 more source
Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer
Molecular Oncology, EarlyView.Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte +10 more
wiley +1 more source
An Artificial Intelligence Model for Early Stage Breast Cancer Detection from Biopsy Images [PDF]
arXivAccurate identification of breast cancer types plays a critical role in guiding treatment decisions and improving patient outcomes. This paper presents an artificial intelligence enabled tool designed to aid in the identification of breast cancer types using histopathological biopsy images.
arxiv
Is aspiration biopsy of breast cancer dangerous to the patient? [PDF]
, 1954 Guy F. Robbins +3 more
openalex +1 more source
Molecular Oncology, EarlyView.Comprehensive cancer centre (CCCs) and CCCs of Excellence (CCCoE) integration in healthcare. Through outreach to surrounding community hospitals, CCCs enable wider access to top‐clinical cancer treatments and care, thereby facilitating the swift enrolment of patients into data‐rich clinical trials (PI‐initiated trials testing new concepts, drug ...
Anton Berns +4 more
wiley +1 more source
Studies in the Genetics of Human Neoplasms: Cancer of the Breast, Based upon 201 Family Histories [PDF]
, 1937 R. P. Martynova
openalex +1 more source
Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma
Molecular Oncology, EarlyView.GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski +19 more
wiley +1 more source
LATE RESULTS AFTER THE RADICAL OPEATION FOR CANCER OF THE BREAST
, 1920 WILLY MEYER
openalex +2 more sources
Molecular Oncology, EarlyView.This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau +9 more
wiley +1 more source